Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghada El-Hajj Fuleihan

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|August 16, 2008
Tibolone and the promise of ideal hormone-replacement therapyGhada El-Hajj Fuleihan
Metabolism: Clinical and Experimental|February 7, 2012
Can the sunshine vitamin melt the fat?Ghada El-Hajj Fuleihan
The Journal of Clinical Endocrinology and Metabolism|January 1, 2020
Building Bridges to Address the Osteoporosis CrisisGhada El-Hajj Fuleihan
The New England Journal of Medicine|January 30, 2004
Strontium ranelate--a novel therapy for osteoporosis or a permutation of the same?Ghada El-Hajj Fuleihan
The Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Hyperparathyroidism: time to reconsider current clinical decision paradigms?Ghada El-Hajj Fuleihan
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Familial benign hypocalciuric hypercalcemiaGhada El-Hajj Fuleihan
Nature Clinical Practice. Endocrinology & Metabolism|August 20, 2008
How effective is risedronate in preventing bone loss in patients on high-dose steroids?Asma Arabi, Ghada El-Hajj Fuleihan
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Treatment of Hypercalcemia of MalignancyMarlene Chakhtoura, Ghada El-Hajj Fuleihan
Clinics in Dermatology|July 11, 2006
Dermatologic manifestations of parathyroid-related disordersGhada El-Hajj Fuleihan, Nelly Rubeiz
Bone|February 1, 2014
Impact of changes in mortality on FRAX-derived fracture probabilitiesOmar I Kreidieh, Ghada El-Hajj Fuleihan
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|August 16, 2008
Tibolone and the promise of ideal hormone-replacement therapyGhada El-Hajj Fuleihan
Metabolism: Clinical and Experimental|February 7, 2012
Can the sunshine vitamin melt the fat?Ghada El-Hajj Fuleihan
The Journal of Clinical Endocrinology and Metabolism|January 1, 2020
Building Bridges to Address the Osteoporosis CrisisGhada El-Hajj Fuleihan
The New England Journal of Medicine|January 30, 2004
Strontium ranelate--a novel therapy for osteoporosis or a permutation of the same?Ghada El-Hajj Fuleihan
The Journal of Clinical Endocrinology and Metabolism|September 6, 2008
Hyperparathyroidism: time to reconsider current clinical decision paradigms?Ghada El-Hajj Fuleihan
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Familial benign hypocalciuric hypercalcemiaGhada El-Hajj Fuleihan
Nature Clinical Practice. Endocrinology & Metabolism|August 20, 2008
How effective is risedronate in preventing bone loss in patients on high-dose steroids?Asma Arabi, Ghada El-Hajj Fuleihan
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Treatment of Hypercalcemia of MalignancyMarlene Chakhtoura, Ghada El-Hajj Fuleihan
Clinics in Dermatology|July 11, 2006
Dermatologic manifestations of parathyroid-related disordersGhada El-Hajj Fuleihan, Nelly Rubeiz
Bone|February 1, 2014
Impact of changes in mortality on FRAX-derived fracture probabilitiesOmar I Kreidieh, Ghada El-Hajj Fuleihan
Pageof 15